Physician profile
Dennis M Timko
NPI 1013931815
$5,565.25
in general payments reported to CMS, 2019-2025
31 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,855 · 2020: $94.88 · 2021: $1,354 · 2022: $1,293 · 2023: $524 · 2024: $283 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $969.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $968.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $3,371.95 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $736.06 | 2019-2023 | Tapestry, Juggerknotless Soft Anchor |
| Paratek Pharmaceuticals, INC. | $297.30 | 2021-2025 | Nuzyra |
| Zyla Life Sciences, INC. | $193.87 | 2019 | |
| Tactile Systems Technology INC | $134.59 | 2020-2021 | |
| Cook Medical LLC | $91.39 | 2024 | Zilver Ptx |
| Medtronic, INC. | $80.71 | 2022-2023 | Vanta Adaptivestim, Intellis Adaptivestim |
| Organogenesis INC. | $79.24 | 2019-2025 | Puraply Am, Novachor |
| Vaporox, INC. | $69.05 | 2023 | Vht-200 Wound Treatment System |
| Abbvie INC. | $56.83 | 2023 | Ubrelvy |
| Astrazeneca Pharmaceuticals LP | $48.74 | 2023 | Evusheld, Flumist Quadrivalent |
| Kerecis Limited | $42.83 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen |
| Wright Medical Technology, INC. | $42.54 | 2019 | |
| Horizon Therapeutics Plc | $31.92 | 2023 | Krystexxa |
| Exact Sciences Corporation | $27.88 | 2023 | Cologuard Collection Kit |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xtant Medical INC | $26.57 | 2021 | |
| Averitas Pharma INC. | $22.22 | 2023 | Qutenza |
| Ucb, INC. | $20.69 | 2023 | Cimzia |
| Lilly USA, LLC | $18.45 | 2023 | Taltz |
| Idorsia Pharmaceuticals US INC | $17.20 | 2023 | Quviviq |
| Solventum Corporation | $16.74 | 2025 | V.A.C.Ulta, Promogran Prisma, Activ.A.C. |
| Nevro Corp. | $16.15 | 2022 | |
| Lifenet Health | $15.13 | 2024 | Theragenesis Wound Matrix |
| Biocomposites INC | $14.46 | 2025 | Stimulan |
| Smith+Nephew, INC. | $14.23 | 2020 | |
| Cashflow Solutions, LLC | $13.93 | 2023 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Merck Sharp & Dohme LLC | $13.87 | 2019 | |
| Abbott Laboratories | $13.44 | 2023 | Proclaim |
| Arteriocyte Medical Systems, INC. | $13.39 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $12.00 | 2021 | |
| Integra Lifesciences Corporation | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Timko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.